The annual cost of alcohol-related liver disease in the United States is projected to more than double, from $31 billion in 2022 to $66 billion in 2040, a new analysis has found.
Consuming sugar-sweetened drinks, but not artificially sweetened beverages, may be associated with higher rates of liver cancer and death from liver disease, new data show.
Alcohol-related mortality rates have risen recently among both men and women, but the rate of increase has been higher among females across different demographic categories.
Alcohol abstinence was achieved by nearly two thirds of patients with alcohol use disorder (AUD) and cirrhosis after taking naltrexone, with minimal adverse events.